Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CD43 Inhibitors

CD43, also known as sialophorin, is a highly glycosylated transmembrane protein predominantly expressed on the surface of leukocytes, where it plays a multifaceted role in mediating various aspects of the immune response. This protein is involved in the regulation of cell adhesion, migration, and the activation of T cells, contributing to its critical function in the immune system's ability to respond to pathogens. The extensive glycosylation of CD43 imparts a negative charge to the cell surface, which aids in the repulsion of other negatively charged cells, thereby modulating cell-cell interactions within the immune system. Additionally, CD43 extends outward from the cell membrane, acting as a physical barrier that modulates the accessibility of the cell surface to external factors, including pathogens and signaling molecules. This unique structure and function of CD43 underscore its importance in the immune surveillance and response mechanisms, facilitating the dynamic interplay between immune cells and their environment. The inhibition of CD43 function can significantly impact the immune system's efficacy, altering leukocyte behavior and compromising the body's defense mechanisms against infections and diseases. Inhibition can occur through various mechanisms, including the binding of antibodies or other molecules to CD43, which can block its interaction with ligands and signaling partners, thereby hindering its role in cell adhesion and migration. Additionally, genetic modifications or pharmacological agents that reduce the expression of CD43 on the cell surface can also inhibit its function, affecting the immune cell's ability to respond to inflammatory signals and migrate to sites of infection or injury. Furthermore, alterations in the glycosylation pattern of CD43 can modify its structural properties and interactions with other molecules, potentially inhibiting its normal function and impacting the immune response. Understanding the mechanisms by which CD43 can be inhibited offers valuable insights into its role in immune regulation and the potential consequences of its dysregulation, highlighting the complexity of immune system modulation and the critical function of CD43 in maintaining immune homeostasis.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Phosphoinositide 3-kinase (PI3K) inhibitor influencing CD43 by disrupting PI3K signaling, which can affect CD43 expression and cellular processes related to its function.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor indirectly modulating CD43 by impacting downstream signaling pathways that influence CD43 expression and function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor influencing CD43 by disrupting PI3K signaling, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function.

Calmidazolium chloride

57265-65-3sc-201494
sc-201494A
10 mg
50 mg
$156.00
$612.00
27
(1)

Calmodulin inhibitor indirectly impacting CD43 by modulating calcium-dependent signaling pathways that influence CD43 expression and function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor influencing CD43 indirectly by modulating mTOR signaling, leading to alterations in CD43 expression and cellular processes related to its function.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

Inhibitor of NF-κB signaling indirectly influencing CD43 by disrupting NF-κB-mediated transcriptional regulation, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function.

A-769662

844499-71-4sc-203790
sc-203790A
sc-203790B
sc-203790C
sc-203790D
10 mg
50 mg
100 mg
500 mg
1 g
$184.00
$741.00
$1076.00
$3417.00
$5304.00
23
(2)

AMP-activated protein kinase (AMPK) activator that indirectly modulates CD43 by influencing cellular energy status and downstream signaling pathways that impact CD43 expression and function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor indirectly influencing CD43 by disrupting the MAPK/ERK signaling pathway, leading to altered CD43 expression and cellular processes associated with CD43 function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor indirectly modulating CD43 by disrupting p38 MAPK signaling, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK1/2 inhibitor indirectly impacting CD43 by disrupting the MAPK/ERK signaling pathway, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function.